MetaCap

MaxCyte (MXCT) Stock Chart

NASDAQ: MXCTHealth CareBiotechnology: Commercial Physical & Biological ResarchUSD

1.04-0.05 (-4.59%)

At close: Oct 7, 4:00 PM ET · Delayed 15 min

MXCT technical summary

MXCT is trading 13.8% below its 50-day simple moving average of $1.21 and 3.3% below its 200-day average of $1.08. The 50-day average is above the 200-day average, a configuration technical analysts associate with a longer-term uptrend. The 14-day Relative Strength Index (RSI) is 32.1, within the neutral 30 to 70 band.

Over the past year, the stock ranged from $0.643 (Feb 17, 2026) to $1.87 (Oct 16, 2025); the current price sits 32% of the way from the low to the high. Annualized 30-day volatility is 42.0%. Based on the last session's high, low and close, the classic pivot point is $1.05, with first resistance at $1.07 and first support at $1.03.

These indicators describe past price behavior for MaxCyte; they are not predictions.

Summary generated from market data by MetaCap's automated system. Methodology

Technical indicators

Beta
—
1Y high
1.87 (Oct 16)
1Y low
0.643 (Feb 17)
Last close
1.04

MXCT price performance

1 week

-7.14%

1 month

-18.43%

3 months

-18.75%

6 months

+37.93%

Year to date

-32.90%

1 year

-32.90%

3 years

-64.26%

5 years

-90.57%

MXCT price return, excluding dividends.

Moving averages

Simple and exponential moving averages
PeriodSimple (SMA)Exponential (EMA)
5-day1.07Price below1.08Price below
10-day1.12Price below1.11Price below
20-day1.16Price below1.15Price below
50-day1.21Price below1.18Price below
100-day1.20Price below1.17Price below
200-day1.08Price below1.19Price below

Moving averages are computed from daily closing prices over the past year. What is a moving average?

Pivot points

Classic pivot points
LevelPrice
Resistance 3 (R3)1.11
Resistance 2 (R2)1.09
Resistance 1 (R1)1.07
Pivot point1.05
Support 1 (S1)1.03
Support 2 (S2)1.01
Support 3 (S3)0.9867

Classic floor-trader pivots from the last session's high, low and close. How pivot points work

Learn technical analysis